In 2019, the field of personalized medicine continued to grow with the market launch of more than two dozen drugs targeting novel genomic alterations and numerous genetic tests to determine whether patients are at risk for serious diseases like cancer, and whether...
Investigators at Ambry Genetics, the Mayo Clinic in Rochester, the University of Utah, and the University of California at Irvine have tapped into Ambry’s large collection of multigene panel test results to clarify hereditary cancer associations in high-risk...
Last Updated: January 8, 2019 This article is part of a series built to highlight rare hereditary cancer syndromes. Here’s one woman’s story of living with MUTYH-Associated polyposis (MAP). Genetic Counseling Note: MUTYH is a cancer...
